Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nalpropion Pharmaceuticals, Inc.

https://www.nalpropion.com/

Latest From Nalpropion Pharmaceuticals, Inc.

Novo Nordisk’s Wegovy Gets EU Thumbs Up But Launch Will Wait

Wegovy is set to join Saxenda as the company’s second EU approved drug for obesity, helping it corner the region’s weight-management market, once the company gets its supply back on track.

Approvals Companies

US FDA Actions On Rx Drug Promos Covered New Territory Last Year

Office of Prescription Drug Promotion issued just six letters citing companies for improper drug promotion in 2020, including the placement of safety information in an email and making unfounded COVID-19 claims. New research projects focus on celebrity endorsements, medical conference materials.

Advertising, Marketing & Sales FDA
See All

Company Information

  • Other Names / Subsidiaries
    • Currax Pharmaceuticals LLC
    • Orexigen Therapeutics, Inc.
UsernamePublicRestriction

Register